Multiple sclerosis: Natalizumab to fingolimod--the washout whitewash.
Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, Germany.
Martin
M
Stangel
Neurology Section, VA North Texas Health Care System, Medical Service Dallas, VA Medical Centre, 4500 South Lancaster Road, Dallas, TX 75216, USA.
Olaf
O
Stüve
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D057915:Drug Substitution / Q000379:methods*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives*
D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D013110:Sphingosine